<DOC>
	<DOCNO>NCT00605631</DOCNO>
	<brief_summary>This study design evaluate effect pace post-MI patient .</brief_summary>
	<brief_title>The Prevention Myocardial Enlargement Dilatation Post Myocardial Infarction Study</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<criteria>Age 18 , legal age give inform consent specific state national law Willing capable providing informed consent , participate test associate clinical investigation approve clinical investigational center interval define protocol Patient clinically document anterior myocardial infarction occur within last 14 day Measured peak CK &gt; 2000 mU/mL within 72 hour MI . QRS duration &lt; 120 m measure 12lead ECG time recent MI Patient atrial tachyarrhythmia permanent ( i.e. , terminate spontaneously terminate medical intervention ) persistent ( i.e. , terminate medical intervention , terminate spontaneously ) time enrollment Patient cardiogenic shock define systolic blood pressure &lt; 90 mmHg pressor/inotrope medication time potential enrollment Patient 2 3 degree heart block time potential enrollment Patient undergone schedule coronary artery bypass graft procedure , 30 day 30 day date potential enrollment Patient know life expectancy le 6 month due non cardiac cause Patient mark renal dysfunction define Creatinine &gt; 2.5 mg/dL time enrollment Patient enrol concurrent study may confound result study Patient class IV heart failure Patient heart transplant list Patient already implant pacemaker , ICD , CRT device Patient pregnant plan pregnant course study Both</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Pacing</keyword>
</DOC>